IBD Associated with Increased risk of Autoimmune and Inflammatory Diseases
A registry based study has shown higher rates of…
rheumnow.com
The JAK-STAT Pathway in Inflammatory Bowel Disease
Russell D. Cohen, MD, and Thomas A. Ullman, MD, summarize clinical data on JAK inhibitors in inflammatory bowel disease (IBD). In addition to discussing the rationale for targeting JAK-STAT…
annenberg.net
US FDA accepts Pfizer’s sNDA for Xeljanz to treat ulcerative colitis
The US Food and Drug Administration (FDA) has accepted for filing Pfizer’s supplemental New Drug Application (sNDA) for Xeljanz (tofacitinib citrate), an…
pharmaceutical-technology.com